CompletedNot Applicable

Overlooked Barrier To Discontinuing Bont-A Therapy

Turkey (Türkiye)81 participantsStarted 2024-09-23

Plain-language summary

This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation. This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * included chronic-phase ischemic or hemorrhagic stroke and spasticity in the upper and/or lower limbs. Exclusion Criteria: * Patients younger than 18 years, those who had passed away, and those who could not be reached by phone were excluded from the study.

What they're measuring

Primary Outcome

Timeframe: 2012-2024

Primary Outcome

Timeframe: 2012-2024

Trial details

NCT IDNCT07422428

SponsorSuleyman Demirel University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-10

View on ClinicalTrials.gov More Post Stroke Spastic Hemiplegia trials